Pfizer (PFE) Net Income Attributable to Noncontrolling Interests (2009 - 2026)
Pfizer (PFE) reported Net Income Attributable to Noncontrolling Interests of $10 million for Q3 2026, up 11.1% from $9 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Net Income Attributable to Noncontrolling Interests (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 27, 2026, Pfizer's Net Income Attributable to Noncontrolling Interests came in at $36 million, down 12.2% year-over-year; for FY2025, it was $41 million, up 32.3% from FY2024.
- Net Income Attributable to Noncontrolling Interests has a five-year compound annual growth rate of 2.6% (FY2020 to FY2025).
- By year, Net Income Attributable to Noncontrolling Interests came in at $31 million in FY2024 (-20.5%), $39 million in FY2023 (+11.4%), $35 million in FY2022 (-22.2%) and $45 million in FY2021 (+25.0%).
- Five-year quarterly Net Income Attributable to Noncontrolling Interests spans a low of -$2 million in Q4 2021 and a high of $18 million in Q2 2025.
- Year over year, Net Income Attributable to Noncontrolling Interests gained in four of the last eight quarters, with growth averaging 16.7%.
- The high point for year-over-year Net Income Attributable to Noncontrolling Interests in five years was Q2 2025 (growth of 157.1%); the low point was Q2 2022 (a decline of 76.9%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $10 million (Q2 2026), $8 million (Q1 2026) and $8 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | - |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 10.00 Mn |
| Jun 28, 2026 | 10.00 Mn |
| Mar 29, 2026 | 8.00 Mn |
| Dec 31, 2025 | 8.00 Mn |
| Sep 28, 2025 | 9.00 Mn |
| Jun 29, 2025 | 18.00 Mn |
| Mar 30, 2025 | 6.00 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 29, 2024 | 8.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Oct 1, 2023 | 6.00 Mn |
| Jul 2, 2023 | 11.00 Mn |
| Apr 2, 2023 | 13.00 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Oct 2, 2022 | 15.00 Mn |
| Jul 3, 2022 | 6.00 Mn |
| Apr 3, 2022 | 6.00 Mn |
| Dec 31, 2021 | -2.00 Mn |
API Access
Pfizer Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();